[Modification of chemical carcinogenesis with adrenergic compounds].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004052:Diethylnitrosamine / Q000037:antagonists & inhibitors; D004336:Drug Antagonism; D004938:Esophageal Neoplasms / Q000139:chemically induced*; D008113:Liver Neoplasms / Q000139:chemically induced*; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D009602:Nitrosamines; D009638:Norepinephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats
D000317:Adrenergic alpha-Antagonists; D009602:Nitrosamines; D004052:Diethylnitrosamine; D011433:Propranolol; D009638:Norepinephrine
Modifikatsiia khimicheskogo kantserogeneza adrenergicheskimi soedineniiami.